For the Inventor, By the Inventor

Enter assignee name

Suresnes, France

Les Laboratoires Servier

USPTO Granted Patents = 290

CIPO Patents = 75

EPO Patents = 146

Trademarks = 8

Forward Citations = 774

Loading Chart...

Loading Chart...

512 inventors (with patents filed for the assignee):

Pierre Renard (32 out of 175 patents)

Jean-Pierre Lecouve (30 out of 40 patents)

Olivier Geneste (28 out of 34 patents)

4. Pierre Lestage (27 out of 42 patents)

5. James Brooke Murray (25 out of 28 patents)

6. Guillaume De Nanteuil (22 out of 61 patents)

7. James Edward Paul Davidson (22 out of 25 patents)

8. Mark Millan (22 out of 55 patents)

9. I-Jen Chen (21 out of 27 patents)

10. Jean-Louis Peglion (20 out of 52 patents)

11. Philippe Delagrange (19 out of 42 patents)

12. Jean-Claude J Souvie (19 out of 27 patents)

13. Thierry Le Diguarher (17 out of 19 patents)

14. John Hickman (17 out of 24 patents)

15. Alain Pierre (17 out of 46 patents)

Core Competencies:

Polygenic Risk Scores

Anti-FLT3 Antibodies

Chimeric Antigen Receptor T Cells

MCL-1 Inhibitors

Combination Therapies

Monoclonal Antibodies

Cancer Treatment

Pharmaceutical Compositions

Bicyclic Derivatives

Indole Compounds

Pyrrole Compounds

Liposomal Formulations

290 patents: Sort by Forward Citations

1. 12467091 - Polygenic risk scores for predicting disease complications and/or response to therapy (2025-11-11),

2. 12252539 - Anti-FLT3 antibodies and compositions (2025-03-18),

3. 12221462 - Methods and compositions for dosing of allogeneic chimeric antigen receptor T cells (2025-02-11),

4. 12129261 - Crystalline forms of a MCL-1 inhibitor, a process for their preparation and pharmaceutical compositions containing them (2024-10-29),

5. 12077534 - Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancer (2024-09-03),

6. 12030942 - Anti-PD-1 antibodies and compositions (2024-07-09),

7. 12012450 - Anti-NKG2A antibodies and compositions (2024-06-18),

8. 11987829 - Method for the biosynthesis of diosmin and/or hesperidin in a microorganism (2024-05-21),

9. 11939380 - Combination therapies targeting PD-1, TIM-3, and LAG-3 (2024-03-26),

10. 11833162 - Macrocyclic derivatives, process for preparing same and pharmaceutical compositions containing same (2023-12-05),

11. 11807688 - Anti-AXL antibodies and compositions (2023-11-07),

12. 11634500 - Anti-CD73 antibodies and compositions (2023-04-25),

13. 11613753 - Methods and pharmaceutical compositions for treating tubulin carboxypeptidases associated diseases (2023-03-28),

14. 11512062 - Process for the synthesis of piperazinyl-ethoxy-bromophenyl derivates and their application in the production of compounds containing them (2022-11-29),

15. 11466023 - Combination of a Mcl-1 inhibitor and a standard of care treatment for hematologic cancers, uses and pharmaceutical compositions thereof (2022-10-11),

LES LABORATOIRES SERVIER is an international pharmaceutical company founded in France in 1954. Servier specializes in ethical pharmaceuticals and operates in various therapeutic areas including cardiovascular diseases, neurology, oncology, and rheumatology. With a global presence in over 150 countries, Servier is committed to developing innovative medications that improve patients' lives. For more information, please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

290 Patents

#1 in Suresnes

#83 in France

#2,972 in the World

Suresnes, France

Les Laboratoires Servier

Forward Citations = 774

512 inventors:

Pierre Renard (32 out of 175 patents)

Jean-Pierre Lecouve (30 out of 40 patents)

Olivier Geneste (28 out of 34 patents)

4. Pierre Lestage (27 out of 42 patents)

5. James Brooke Murray (25 out of 28 patents)

Please report any incorrect information to support@idiyas.com

Loading…